Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 08/09/17

Funding Opportunities

Recent Funding Opportunity Announcements

Title Announcement Number Opening Date Expiration Date Activity Code
Discovery of Small Molecule Immunomodulators for Cancer Therapy PAR-17-331 Sep 5, 2017 May 8, 2020 R01
Assay Development and Screening for Discovery of Chemical Probes or Therapeutic Agents PA-17-438 Sep 5, 2017 May 8, 2020 R01

DCTD Funding Opportunity in Translational Research

Title Announcement Number Opening Date Expiration Date Activity Code
NCI Clinical and Translational Exploratory/Developmental Studies PAR-16-176 June 16, 2016 March 23, 2018 R21

NIH Parent Announcements

About the Branch Chief

Dr. Sundar Venkatachalam Dr. Sundar Venkatachalam serves as the chief of PTGB. Sundar earned his Ph.D. in Biochemistry from the Ohio State University, where he studied the molecular mechanisms of DNA damage and repair responses induced by polycyclic aromatic hydrocarbons. As a postdoctoral fellow at the Baylor College of Medicine, he analyzed the role of the p53 haploinsufficiency in tumor susceptibility and aging using genetically engineered mouse models. More…